The ‘in vivo’ survival characteristics of factor VIII procoagulant antigen (VIII:C Ag) in haemophilia A subjects
- 1 January 1982
- journal article
- research article
- Published by Elsevier in Thrombosis Research
- Vol. 25 (1-2) , 33-39
- https://doi.org/10.1016/0049-3848(82)90212-2
Abstract
No abstract availableKeywords
This publication has 10 references indexed in Scilit:
- Factor VIII:C and VIII:CAg Response in Patients with Haemophilia A and von Willebrand's Disease after Administration of Different Factor VIII Concentrates or PlasmaBritish Journal of Haematology, 1981
- A Radial Immunodiffusion Method for the Assay of Factor VIII:C Antigen (VIII:C Ag) in PlasmaBritish Journal of Haematology, 1981
- Characteristics of the Factor VIII Protein and Factor XIII in Various Factor VIII ConcentratesScandinavian Journal of Haematology, 1980
- Measurement of Antihaemophilic Factor A Antigen (VIII:CAg) with a Solid Phase Immunoradiometric Method Based on Homologous Non‐Haemophilic AntibodiesScandinavian Journal of Haematology, 1979
- An Immunoradiometric Assay for Procoagulant Factor VIII Antigen: Results in Haemophilia, von Willebrand's Disease and Fetal Plasma and SerumBritish Journal of Haematology, 1979
- In Vivo Recovery of Factor VIII: A Comparison of One-Stage and Two-Stage Assay MethodsThrombosis and Haemostasis, 1979
- Discrepancy between One‐stage and Two‐stage Assay of Factor VIII:CBritish Journal of Haematology, 1978
- Treatment of Hemophilia with Glycine-Precipitated Factor VIIINew England Journal of Medicine, 1966
- The in vivo Longevity of Antihaemophilic Factor (Factor VIII)British Journal of Haematology, 1964
- The Assay of Antihaemophilic-Globulin ActivityBritish Journal of Haematology, 1955